Efficacy of D‐cycloserine augmented brief intensive cognitive‐behavioural therapy for paediatric obsessive‐compulsive disorder: A randomised clinical trial

Objective To examine the efficacy of weight‐adjusted D‐cycloserine (DCS) (35 or 70 mg) relative to placebo augmentation of intensive exposure therapy for youth with obsessive‐compulsive disorder (OCD) in a double‐blind, randomised controlled trial, and examine whether antidepressant medication or pa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Depression and anxiety 2022-06, Vol.39 (6), p.461-473
Hauptverfasser:	Farrell, Lara J., Waters, Allison M., Tiralongo, Evelin, Mathieu, Sharna, McKenzie, Matthew, Garbharran, Vinay, Ware, Robert S., Zimmer‐Gembeck, Melanie J., McConnell, Harry, Lavell, Cassie, Cadman, Jacinda, Ollendick, Thomas H., Hudson, Jennifer L., Rapee, Ronald M., McDermott, Brett, Geller, Daniel, Storch, Eric A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressants Behavior modification Clinical trials Cognitive ability Cognitive behavioral therapy cognitive‐behaviour therapy Cycloserine D‐cycloserine exposure therapy Obsessive compulsive disorder OCD Pediatrics Placebos
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!